FDA Approved: ERTAPENEM — Supplemental Application (ENDO USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ertapenem (ERTAPENEM SODIUM) submitted by ENDO USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Complicated Intra-abdominal Infections
• Complicated Skin and Skin Structure Infections
• Gynecologic Infections

Drugs mentioned

• ERTAPENEM (ertapenem)

Snippet

SUPPL AP for ERTAPENEM (ERTAPENEM SODIUM)